Profund Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $274K | Sell |
|
|||||
|
2025
Q1 | $288K | Buy |
|
|||||
|
2024
Q4 | $276K | Sell |
|
|||||
|
2024
Q3 | $330K | Sell |
|
|||||
|
2024
Q2 | $299K | Buy |
|
|||||
|
2024
Q1 | $227K | Sell |
|
|||||
|
2023
Q4 | $283K | Buy |
|
|||||
|
2023
Q3 | $266K | Buy |
|
|||||
|
2023
Q2 | $247K | Sell |
|
|||||
|
2023
Q1 | $311K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $245K | Sell |
|
|||||
|
2018
Q3 | $498K | Sell |
|
|||||
|
2018
Q2 | $677K | Buy |
|
|||||
|
2018
Q1 | $465K | Buy |
|
|||||
|
2017
Q4 | $296K | Buy |
|
|||||
|
2017
Q3 | $253K | Sell |
|
|||||
|
2017
Q2 | $398K | Buy |
|
|||||
|
2017
Q1 | $273K | Sell |
|
|||||
|
2016
Q4 | $245K | Buy |
|